annual CFI:
$99.33M+$43.55M(+78.08%)Summary
- As of today (July 1, 2025), TVTX annual cash flow from investing activities is $99.33 million, with the most recent change of +$43.55 million (+78.08%) on December 31, 2024.
- During the last 3 years, TVTX annual CFI has risen by +$236.95 million (+172.17%).
- TVTX annual CFI is now at all-time high.
Performance
TVTX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$41.29M+$121.60M(+151.41%)Summary
- As of today (July 1, 2025), TVTX quarterly cash flow from investing activities is $41.29 million, with the most recent change of +$121.60 million (+151.41%) on March 31, 2025.
- Over the past year, TVTX quarterly CFI has dropped by -$63.61 million (-60.64%).
- TVTX quarterly CFI is now -69.03% below its all-time high of $133.32 million, reached on September 30, 2023.
Performance
TVTX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$35.72M-$63.61M(-64.04%)Summary
- As of today (July 1, 2025), TVTX TTM cash flow from investing activities is $35.72 million, with the most recent change of -$63.61 million (-64.04%) on March 31, 2025.
- Over the past year, TVTX TTM CFI has dropped by -$162.00 million (-81.93%).
- TVTX TTM CFI is now -85.71% below its all-time high of $249.88 million, reached on June 30, 2024.
Performance
TVTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TVTX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +78.1% | -60.6% | -81.9% |
| 3 y3 years | +172.2% | +24.5% | +2761.9% |
| 5 y5 years | +400.1% | +4.4% | -68.5% |
TVTX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +172.2% | -69.0% | +151.4% | -85.7% | +134.8% |
| 5 y | 5-year | at high | +172.2% | -69.0% | +132.9% | -85.7% | +110.3% |
| alltime | all time | at high | +148.9% | -69.0% | +125.6% | -85.7% | +110.3% |
TVTX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $41.29M(-151.4%) | $35.72M(-64.0%) |
| Dec 2024 | $99.33M(+78.1%) | -$80.31M(-274.1%) | $99.33M(-38.9%) |
| Sep 2024 | - | $46.13M(+61.2%) | $162.68M(-34.9%) |
| Jun 2024 | - | $28.61M(-72.7%) | $249.88M(+26.4%) |
| Mar 2024 | - | $104.90M(-718.9%) | $197.71M(+254.5%) |
| Dec 2023 | $55.78M(-271.3%) | -$16.95M(-112.7%) | $55.78M(+54.8%) |
| Sep 2023 | - | $133.32M(-666.0%) | $36.02M(-141.3%) |
| Jun 2023 | - | -$23.55M(-36.4%) | -$87.21M(-15.1%) |
| Mar 2023 | - | -$37.04M(+0.9%) | -$102.76M(+215.7%) |
| Dec 2022 | -$32.55M(-76.3%) | -$36.70M(-464.1%) | -$32.55M(-382.6%) |
| Sep 2022 | - | $10.08M(-125.8%) | $11.52M(-66.1%) |
| Jun 2022 | - | -$39.10M(-217.9%) | $33.96M(+2621.1%) |
| Mar 2022 | - | $33.16M(+350.0%) | $1.25M(-100.9%) |
| Dec 2021 | -$137.62M(+124.4%) | $7.37M(-77.3%) | -$137.62M(-49.1%) |
| Sep 2021 | - | $32.52M(-145.3%) | -$270.50M(-21.9%) |
| Jun 2021 | - | -$71.81M(-32.1%) | -$346.19M(+67.6%) |
| Mar 2021 | - | -$105.71M(-15.8%) | -$206.58M(+236.9%) |
| Dec 2020 | -$61.33M(-408.7%) | -$125.51M(+190.7%) | -$61.33M(-193.3%) |
| Sep 2020 | - | -$43.17M(-163.7%) | $65.76M(-42.0%) |
| Jun 2020 | - | $67.80M(+71.4%) | $113.40M(+60.1%) |
| Mar 2020 | - | $39.55M(+2403.2%) | $70.83M(+256.6%) |
| Dec 2019 | $19.86M(-109.8%) | $1.58M(-64.6%) | $19.86M(-165.1%) |
| Sep 2019 | - | $4.46M(-82.3%) | -$30.52M(-84.5%) |
| Jun 2019 | - | $25.23M(-321.1%) | -$196.53M(+1.4%) |
| Mar 2019 | - | -$11.41M(-76.6%) | -$193.85M(-4.6%) |
| Dec 2018 | -$203.29M | -$48.80M(-69.8%) | -$203.29M(+31.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$161.54M(-678.9%) | -$154.59M(-3344.3%) |
| Jun 2018 | - | $27.91M(-233.8%) | $4.76M(-76.9%) |
| Mar 2018 | - | -$20.85M(>+9900.0%) | $20.63M(-54.8%) |
| Dec 2017 | $45.60M(+339.7%) | -$103.00K(-95.3%) | $45.60M(-40.1%) |
| Sep 2017 | - | -$2.19M(-105.0%) | $76.17M(+5.3%) |
| Jun 2017 | - | $43.77M(+961.0%) | $72.31M(+198.2%) |
| Mar 2017 | - | $4.13M(-86.5%) | $24.25M(+133.9%) |
| Dec 2016 | $10.37M(-112.9%) | $30.47M(-603.5%) | $10.37M(-108.6%) |
| Sep 2016 | - | -$6.05M(+41.0%) | -$120.56M(+93.6%) |
| Jun 2016 | - | -$4.29M(-56.0%) | -$62.29M(+4.6%) |
| Mar 2016 | - | -$9.76M(-90.3%) | -$59.55M(-26.1%) |
| Dec 2015 | -$80.60M(+116.3%) | -$100.46M(-292.4%) | -$80.60M(-469.2%) |
| Sep 2015 | - | $52.22M(-3462.7%) | $21.83M(-167.3%) |
| Jun 2015 | - | -$1.55M(-95.0%) | -$32.46M(-12.2%) |
| Mar 2015 | - | -$30.81M(-1664.0%) | -$36.96M(-0.8%) |
| Dec 2014 | -$37.26M(+589.3%) | $1.97M(-195.5%) | -$37.26M(-1.9%) |
| Sep 2014 | - | -$2.06M(-65.9%) | -$37.97M(-8.0%) |
| Jun 2014 | - | -$6.06M(-80.5%) | -$41.26M(+17.2%) |
| Mar 2014 | - | -$31.11M(-2560.7%) | -$35.21M(+551.4%) |
| Dec 2013 | -$5.41M(+218.1%) | $1.26M(-123.6%) | -$5.41M(-19.0%) |
| Sep 2013 | - | -$5.36M(>+9900.0%) | -$6.67M(+407.1%) |
| Jun 2013 | - | -$8600.00(-99.3%) | -$1.32M(+0.7%) |
| Mar 2013 | - | -$1.31M(<-9900.0%) | -$1.31M(<-9900.0%) |
| Dec 2012 | -$1.70M | - | - |
| Aug 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2010 | - | $0.00 | $0.00 |
FAQ
- What is Travere Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Travere Therapeutics?
- What is Travere Therapeutics annual CFI year-on-year change?
- What is Travere Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Travere Therapeutics?
- What is Travere Therapeutics quarterly CFI year-on-year change?
- What is Travere Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Travere Therapeutics?
- What is Travere Therapeutics TTM CFI year-on-year change?
What is Travere Therapeutics annual cash flow from investing activities?
The current annual CFI of TVTX is $99.33M
What is the all time high annual CFI for Travere Therapeutics?
Travere Therapeutics all-time high annual cash flow from investing activities is $99.33M
What is Travere Therapeutics annual CFI year-on-year change?
Over the past year, TVTX annual cash flow from investing activities has changed by +$43.55M (+78.08%)
What is Travere Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TVTX is $41.29M
What is the all time high quarterly CFI for Travere Therapeutics?
Travere Therapeutics all-time high quarterly cash flow from investing activities is $133.32M
What is Travere Therapeutics quarterly CFI year-on-year change?
Over the past year, TVTX quarterly cash flow from investing activities has changed by -$63.61M (-60.64%)
What is Travere Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TVTX is $35.72M
What is the all time high TTM CFI for Travere Therapeutics?
Travere Therapeutics all-time high TTM cash flow from investing activities is $249.88M
What is Travere Therapeutics TTM CFI year-on-year change?
Over the past year, TVTX TTM cash flow from investing activities has changed by -$162.00M (-81.93%)